SCHEMBL4724055

SCHEMBL4724055

CCOc1ccc2ccccc2c1C1=CC=CO[C]1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.47
DHFR P00374 1/20 0.40
MAPT P10636 1/20 0.39
ALDH1A1 P00352 4/20 0.38
S1PR1 P21453 3/20 0.37
S1PR3 Q99500 1/20 0.37
KDM4E B2RXH2 1/20 0.36
CXCR5 P32302 1/20 0.35
MAPK1 P28482 2/20 0.35
HPGD P15428 1/20 0.35
TSHR P16473 2/20 0.35
NPSR1 Q6W5P4 1/20 0.35
LMNA P02545 2/20 0.34
RAB9A P51151 1/20 0.34
HSD17B10 Q99714 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
PTGS2 P35354 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4767156 0.90 CNR1 (0.40) ALOX5MAPTTSHRTDP1
SCHEMBL4720025 0.89 GAA (0.47) ALOX5MAPTTDP1
SCHEMBL4767263 0.85 MAPT (0.57) MAPTALDH1A1KDM4EHPGDRAB9A
SCHEMBL2045141 0.77 ALOX5 (0.65) ALOX5DHFRMAPTALDH1A1S1PR1
SCHEMBL30142113 0.77 ALOX5 (0.65) ALOX5DHFRMAPTALDH1A1S1PR1
SCHEMBL4724401 0.75 ALDH1A1 (0.43) MAPTALDH1A1KDM4EHPGDTSHR
SCHEMBL5104122 0.72 ALOX5 (0.47) ALOX5DHFRMAPTALDH1A1S1PR1
SCHEMBL14665143 0.70 ALOX5 (0.57) ALOX5DHFRMAPTALDH1A1S1PR1
SCHEMBL29473526 0.70 ALOX5 (0.57) ALOX5DHFRMAPTALDH1A1S1PR1
SCHEMBL12223406 0.70 ALOX5 (0.57) ALOX5DHFRMAPTALDH1A1S1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080176857-A1 4-Piperazinnylthieno[2,3-d]Pyrimidine Compounds as Platelet Aggregation Inhibitors PFIZER INC. 2008-07-24 US disclosed
EP-1874780-A1 4-PIPERAZINYLTHIENO[2,3-D]PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS Pharmacia & Upjohn Company LLC (US) 2008-01-09 EP disclosed
WO-2006100591-A1 4-PIPERAZINNYLTHIENO [2,3-D] PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS PHARMACIA & UPJOHN COMPANY LLC (US) 2006-09-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080176857-A1 4-Piperazinnylthieno[2,3-d]Pyrimidine Compounds as Platelet Aggregation Inhibitors TBXA2R, P2RY4, PF4 ALOX5 245/4885DHFR 283/4885MAPT 4361/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.